Wealth Shield Partners, LLC Cue Biopharma, Inc. Transaction History

Wealth Shield Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$2.49 - $5.92 $74,577 - $177,309	-29,951 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$4.41 - $12.28 $81,615 - $227,265	18,507 Added 161.72%	29,951 $146,000
Q4 2021 Feb 10, 2022	SELL	$10.86 - $17.85 $77,942 - $128,109	-7,177 Reduced 38.54%	11,444 $129,000
Q3 2021 Nov 12, 2021	BUY	$10.06 - $15.3 $81,345 - $123,715	8,086 Added 76.75%	18,621 $271,000
Q2 2021 Aug 06, 2021	BUY	$10.9 - $14.53 $114,831 - $153,073	10,535 New	10,535 $123,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $35.4M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Wealth Shield Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Shield Partners, LLC with notifications on news.